As a brand with a legacy of over 160 years in Africa, we have a deep understanding and belief in the boundless opportunities that this continent presents. Our vision extends beyond mere geography; it encompasses a profound recognition of the potential for growth that resonates within our people, customers, entrepreneurs, and all who share our unwavering commitment and passion for investing in Africa.
With a presence in 20 countries across sub-Saharan Africa, we have cultivated a diverse community of the most skilled, innovative, and creative minds in the industry. Our purpose is to drive Africa's growth, acting as a catalyst for inclusive and sustainable economic development in the regions we serve. We strive to improve the lives of our fellow Africans by conducting business in an ethical and responsible manner.
As a trusted partner, we consistently set higher standards and aspire to become better with each endeavour. We are more than just a banking institution; we are a driving force behind Africa's growth. Join us on this transformative journey. Together, we have the collective power to propel Africa into the future, making tangible progress for all who proudly call Africa home.
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology.
Tandem is the #1 recommended insulin pump brand by people living with diabetes, four years and counting. (dQ&A US Diabetes Connections Patient Panel Report; Net Promoter Score; Q1 2019-Q3 2023: P.49, Q3 2023 (Jan. 2019-Sept. 2023). Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.
SAFETY INFORMATION Please note that this account is not intended to be used for product support or medical advice. If you are having a medical emergency, please dial 911. If you are having an issue with one of our products and need immediate assistance, please call our 24-hour customer support team at 877-801-6901 and press 1 twice.
RX ONLY. Indicated for patients with type 1 diabetes, 6 years and older. WARNING: Control-IQ technology should not be used by people under age 6, or who use less than 10 units of insulin/day, or who weigh less than 55 lbs. Safety info: tandemdiabetes.com/safetyinfo.
Ubiqus language services expand under the Acolad brand. Headquartered in Paris, France, Ubiqus is a global leader in language, transcription, and event services with market-leading divisions in the fields of translation, interpretation, transcription of audio and video, audience polling, audio recording, and event badges. Through the integration of more than 20 companies across North America and Europe, and the ability to extend service coverage and flexibility globally, Ubiqus has been a partner to more than 23,000 clients worldwide.
Ubiqus International: USA | France | Canada | Spain | Ireland | Germany | Belgium | Italy | UK
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.